Milestone Pharmaceuticals Inc (MIST)

Finanzdaten der Milestone Pharmaceuticals Inc-Aktie (MIST)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	134.87%0.56	0.24	-	-	-
Cost Of Revenue	128.57%0.03	0.01	-	-	-
	22.65	-	-	-	-
Selling, General, and Administrative	22.65	-	-	-	-
Research and Development	3.51	-	-	-	-
Costs And Expenses	9.57%26.19	23.90	-	-	-
Operating Income/Loss	8.31%-25.63	-23.66	-17.26	-11.83	-12.53
	9.78%-28.61	-26.07	-17.41	-11.92	-12.97
Attributable To Parent	9.78%-28.61	-26.07	-17.41	-11.92	-12.97
Basic Earnings Per Share	5.00%-0.21	-0.20	-	-0.12	-0.20
Diluted Earnings Per Share	5.00%-0.21	-0.20	-	-0.12	-0.20